Metraipolis › archive › dc_fcd778b8cb87

Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats — Europe PMC PMID:42329290

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42329290
DOI: 10.1007/s10787-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-10-19T06:49:06.340Z
SHA-256 of the archived text: 0eed65aa78087b2e3803b6c1ca408274c0d8bc87658f828a378aa2039a59fbb8
Stable URL of this page: https://metraipolis.com/documento/dc_fcd778b8cb87

How to cite

Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats — Europe PMC PMID:42329290 — Europe PMC (en), https://europepmc.org/article/MED/42329290 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcd778b8cb87 (Metraipolis archive dc_fcd778b8cb87, sha256 0eed65aa78087b2e3803b6c1ca408274c0d8bc87658f828a378aa2039a59fbb8)

BibTeX

@misc{dcfcd778b8cb87,
  title = {Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats — Europe PMC PMID:42329290},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42329290},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcd778b8cb87; sha256 0eed65aa78087b2e3803b6c1ca408274c0d8bc87658f828a378aa2039a59fbb8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42329290. Agents can read the archived copy with the MCP tool read_document.